Denali Therapeutics (DNLI) Return on Sales (2018 - 2024)
Denali Therapeutics (DNLI) reported Return on Sales of 3.31% for Q2 2024, down 332.0% year-over-year from 1.43% in Q3 2023, and down 71187.6% on a QoQ basis from 0.0% in Q1 2024.
Denali Therapeutics (DNLI) has 7 years of Return on Sales data on file, last reported at 3.31% in Q2 2024.
- Quarterly Return on Sales fell 332.0% year-over-year to 3.31% in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 3.31% (down 331.0% YoY) and the FY2023 annual result came in at 0.0%, up 95.0% from the prior year.
- Return on Sales eased to 3.31% in Q2 2024 per DNLI's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.01% in Q4 2020 and bottomed at 700.41% in Q1 2021.
- The 5-year median for Return on Sales is 0.08% (2021), against an average of 46.56%.
- The widest annual swing landed in 2021, when Return on Sales plunged 68949 bps; it then surged 70039 bps in 2022.
- Tracing DNLI's Return on Sales over 5 years: stood at 0.01% in 2020, then sank by 878 bps to 0.06% in 2021, then slumped by 64 bps to 0.1% in 2022, then jumped by 96 bps to 0.0% in 2023, then tumbled by 75286 bps to 3.31% in 2024.
- Per Business Quant, the three latest DNLI Return on Sales figures stand at 3.31% (Q2 2024), 0.0% (Q1 2024), and 0.0% (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -3.31% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.78% |
| Jun 30, 2023 | 0.01% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.10% |
| Sep 30, 2022 | -5.61% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.06% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.04% |
| Mar 31, 2021 | -700.41% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | -116.46% |
| Jun 30, 2020 | -0.10% |
| Mar 31, 2020 | -10.92% |
| Dec 31, 2019 | -0.12% |
| Sep 30, 2019 | -4.82% |
| Jun 30, 2019 | -5.89% |
| Mar 31, 2019 | -0.09% |
| Dec 31, 2018 | 0.01% |
| Sep 30, 2018 | -0.30% |
| Jun 30, 2018 | -0.33% |
| Mar 31, 2018 | -0.40% |